Iron dysregulation in the brains of patients with early onset of Alzheimer’s disease (EOfAD) plays a central role in disease…
Articles by Iqra Mumal, MSc
A rat model genetically engineered to express high levels of two genes can help researchers learn more about the disease…
Bryostatin, Neurotrope Bioscience’s investigational therapy, was associated with improved cognition in advanced Alzheimer’s disease patients in post-hoc (after-the-fact) analysis of…
Takeda Pharmaceutical Company and Zinfandel Pharmaceuticals have brought an early end to a Phase 3 clinical trial after their Alzheimer’s…
An approved treatment for diabetes may help people with Alzheimer’s, a study reports. The research, “Neuroprotective effects of a…
The pharmaceutical company Cortexyme announced that the first group of participants has been dosed in the Phase 1 clinical trial…
Trace levels of lithium in drinking water reduce Alzheimer’s death rates in addition to two risk factors for the disease…
Researchers found that the combination of titanate, a nanoparticle that can penetrate the brain-blood barrier, and cerebrolysin, used in some…
Doctors tend to miss Alzheimer’s diagnosis in psychotic patients more likely than than non-psychotic ones, according to new research by…
Cognition Therapeutics’ lead drug candidate for mild-to-moderate Alzheimer’s disease (AD), CT1812, was shown to be well-tolerated and to lower…